Bank of America Corp DE Buys 398 Shares of STERIS plc (NYSE:STE)

Bank of America Corp DE boosted its stake in shares of STERIS plc (NYSE:STEGet Rating) by 0.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,289,772 shares of the medical equipment provider’s stock after acquiring an additional 398 shares during the quarter. Bank of America Corp DE owned about 1.29% of STERIS worth $311,827,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in STE. Xponance Inc. grew its stake in shares of STERIS by 3.4% during the first quarter. Xponance Inc. now owns 7,648 shares of the medical equipment provider’s stock valued at $1,849,000 after buying an additional 251 shares during the last quarter. CIBC Asset Management Inc grew its stake in shares of STERIS by 1.8% during the first quarter. CIBC Asset Management Inc now owns 5,227 shares of the medical equipment provider’s stock valued at $1,264,000 after buying an additional 90 shares during the last quarter. Van ECK Associates Corp grew its stake in shares of STERIS by 7.2% during the first quarter. Van ECK Associates Corp now owns 10,787 shares of the medical equipment provider’s stock valued at $2,608,000 after buying an additional 724 shares during the last quarter. Values First Advisors Inc. bought a new position in shares of STERIS during the fourth quarter valued at approximately $447,000. Finally, SkyView Investment Advisors LLC grew its stake in shares of STERIS by 838.8% during the fourth quarter. SkyView Investment Advisors LLC now owns 13,388 shares of the medical equipment provider’s stock valued at $315,000 after buying an additional 11,962 shares during the last quarter. 92.04% of the stock is owned by institutional investors.

STERIS Stock Performance

Shares of STE opened at $190.20 on Tuesday. The company has a current ratio of 2.03, a quick ratio of 1.35 and a debt-to-equity ratio of 0.44. The stock has a fifty day moving average price of $208.82 and a 200-day moving average price of $219.78. STERIS plc has a 12 month low of $187.97 and a 12 month high of $255.93. The firm has a market cap of $19.02 billion, a PE ratio of 50.99 and a beta of 0.75.

STERIS Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 23rd. Investors of record on Wednesday, September 7th will be given a $0.47 dividend. This represents a $1.88 annualized dividend and a dividend yield of 0.99%. This is an increase from STERIS’s previous quarterly dividend of $0.43. The ex-dividend date of this dividend is Tuesday, September 6th. STERIS’s dividend payout ratio is presently 50.40%.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on STE shares. TheStreet raised STERIS from a “c+” rating to a “b” rating in a research note on Tuesday, August 2nd. Piper Sandler started coverage on STERIS in a research note on Thursday, July 14th. They issued an “overweight” rating and a $240.00 price objective on the stock. Needham & Company LLC dropped their price objective on STERIS from $248.00 to $237.00 and set a “buy” rating on the stock in a research note on Thursday, August 4th. KeyCorp dropped their price objective on STERIS from $256.00 to $240.00 and set an “overweight” rating on the stock in a research note on Thursday, August 4th. Finally, StockNews.com upgraded STERIS from a “hold” rating to a “buy” rating in a report on Thursday, August 11th. Seven analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $252.00.

STERIS Profile

(Get Rating)

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Read More

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STEGet Rating).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.